Last week’s news and what’s ahead this week illustrate clearly the prominent themes that are redefining the future of U.S. healthcare system. NEWS FROM LAST WEEK Health Reform Plans from…
Read More
The majority of physicians are benefactors of meals or other goodies offered to them by drug or device manufacturers. That’s the key takeaway from ProPublica’s analysis of 56 million payments…
A study released last week found “the estimated cost of waste in the US health care system ranged from $760 billion to $935 billion, accounting for approximately 25% of total…
Three news items from the first week of Fiscal Year 2020 are pivotal to 2020 plans for healthcare investors, operators and policymakers. They focus on the future of Medicare. Here’s…
While all eyes were on D.C. last week as the House of Representatives initiated its impeachment inquiry about President Trump’s dealings with the Ukraine, an important study was released that…
There is consensus that the delivery and financing of care cannot be optimized without a more meaningful focus on personal accountability. The choices individuals make about where they live, the…
Media attention to healthcare is widespread. Two familiar themes surfaced in last week’s news cycle: 1. Health insurance coverage is a surrogate for access to healthcare. In last Thursday’s 3-hour…
Congress returns to DC this week and the agenda for health industry watchers is full: here’s my top 3: Reactions to the Oklahoma opioid verdict against J&J: On August 26,…
Drug company brands Turing, Valeant, Mylan and most recently Purdue, are tarnished because the public saw evidence their leaders put profits above all else. Last week, Purdue Pharma and its…
Last week, the Business Roundtable (BR) released an update to its “Statement on the Purpose of a Corporation” calling for business leaders and boards to expand their focus beyond profitability….
